SEARCH

SEARCH BY CITATION

References

  • Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E. (1998) Evaluation of bone mineral density in children receiving antiepileptic drugs. J Pediatr Neurol 19:129131.
  • Angelopoulou N, Matziari C, Tsimaras V, Sakadamis A, Souftas V, Mandroukas K. (2000) Bone mineral density in adults with Down’s syndrome. Calcif Tissue Int 66:176180.
  • Baroncelli GI, Bertelloni S, Sodini F, Saggese G. (2005) Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs 7:295323.
  • Beerhorst K, Huvers FC, Renier WO. (2005) Severe early onset osteopenia and osteoporosis caused by antiepileptic drugs. J Med 63:222226.
  • Budden SS, Gunness ME. (2003) Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies. J Child Neurol 18:698702.
  • Center J, Beange H, McEldfuff A. (1998) People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard 103:1928.
  • Chung S, Ahn C. (1994) Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 16:382385.
  • Coppola G, Verrotti A, Mainolfi C, Auricchio G, Fortunato D, Operto FF, Pascotto A. (2007) Bone mineral density in Angelman syndrome. Pediatr Neurol 37:411416.
  • Ecevit C, Aydogan A, Kavakli T, Altinoz S. (2004) Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 31:279282.
  • Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A. (2000) Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab 13:933999.
  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 14:58.
  • Ferretti JL, Capozza RF, Cointry GR, García SL, Plotkin H, Alvarez Filgueira ML, Zanchetta JR. (1998) Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone 22:683690.
  • Guo CY, Ronen GM, Atkinson SA. (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 42:11411147.
  • Haas RH, Dixon SD, Sartoris D, Hennessy MJ. (1997) Osteopenia in Rett syndrome. J Pediatr 13:771774.
  • Hay JA. (1995) Development and testing of the Habitual Activity Estimation Scale. In WelsmanJ, KirbyB (Eds) Children and exercise. XIX. Washington Singer Press, Exeter, 2, pp. 125129.
  • Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stallings VA, Stevenson RD. (2002) Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110(1Pt1):e5.
  • Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. (1971) Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J 4:202204.
  • Kafali G, Erselcan T, Tanzer F. (1999) Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr 38:9398.
  • Kanis JA, for the WHO Study Group. (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368381.
  • King W, Levine R, Schmidt R, Oestreich A, Heubi JE. (2003) Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol 45:1216.
  • Lee JJ, Lyne ED, Kleerekoper M, Logan MS, Belfi RA. (1989) Disorders of bone metabolism in severely handicapped children and young adults. Clin Orthop Relat Res 245:297302.
  • Medlinsky HL. (1974) Rickets associated with anticonvulsant medication. Pediatrics 53:9195.
  • Morijiri Y, Sato T. (1981) Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child 56:446449.
  • Mugica I, Ansa J, Sistiaga F, Zabalza R, Zubillaga P, Merino A, Mojedano B, Vidal C. (2002) Digital computerized absorptiometry in the diagnosis of osteoporosis in a group of the severely mentally retarded. Nutr Hosp 17:213218.
  • Samaniego E, Sheth RD. (2007) Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 14:196200.
  • Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K. (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57:445449.
  • Schrager S. (2006) Epidemiology of osteoporosis in women with cognitive impairment. Ment Retard 44:203211.
  • Shaw NJ, White CP, Fraser WD, Rosenbloom L. (1994) Osteopenia in cerebral palsy. Arch Dis Child 71:235238.
  • Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB. (1995) Effect of carbamazepine and valproate on bone mineral density. J Pediatr 127:256262.
  • Sheth RD. (2004) Bone health in pediatric epilepsy. Epilepsy Behav 5(Suppl. 2):S30S35.
  • Sheth RD, Hermann BP. (2007) Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 37:250254.
  • Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, Tsuhkahara Y, Miura M, Mayumi M. (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int 44:247253.
  • Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 43:14881492.
  • Weisman Y, Fattal A, Eisenberg Z, Harel S, Spirer Z, Harell A. (1979) Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy. Br Med J 2:521523.